[go: up one dir, main page]

ES2076975T3 - Aspirina en dosis baja con liberacion controlada. - Google Patents

Aspirina en dosis baja con liberacion controlada.

Info

Publication number
ES2076975T3
ES2076975T3 ES90100032T ES90100032T ES2076975T3 ES 2076975 T3 ES2076975 T3 ES 2076975T3 ES 90100032 T ES90100032 T ES 90100032T ES 90100032 T ES90100032 T ES 90100032T ES 2076975 T3 ES2076975 T3 ES 2076975T3
Authority
ES
Spain
Prior art keywords
granules
controlled release
low dose
protective
pills
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90100032T
Other languages
English (en)
Inventor
Steven Edgar Frisbee
Garret Adare Fitzgerald
William Neil Charman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
STWB Inc
Original Assignee
Sterling Winthrop Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/293,832 external-priority patent/US4970081A/en
Application filed by Sterling Winthrop Inc filed Critical Sterling Winthrop Inc
Application granted granted Critical
Publication of ES2076975T3 publication Critical patent/ES2076975T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

UNA FORMULACION DE BASE ACUOSA PARA GRANULOS DE ASPIRINA QUE PUEDEN SER COMPRESADOS EN PASTILLAS Y QUE MUESTRAN UNAS REPOSICIONES DE ORDEN-CERO DE 5 A 15 MG/HORA SOBRE UN PERIODO DE 5 A 8 HORAS ES DISPUESTA. LA FORMULACION PROTECTORA CONSISTE EN UN COPOLIMERO ACRILATO/METACRILATO HIDROXIPROPILMETILCELULOSA, CLORURO SODICO Y TALCO. LA PASTILLA DE PELICULA PROTECTORA COMPUESTA DE GRANULOS PROTECTORES, GRANULOS DE RELLENO, EXCIPIENTES, ENLACES Y DESINTEGRANTES ES TAMBIEN PROVISTA, ASI COMO, EL PROCESO PARA PREPARAR LAS PASTILLAS Y GRANULOS Y METODO PARA SU USO EN EL TRATAMIENTO DE ENFERMEDADES VASCULARES.
ES90100032T 1989-01-03 1990-01-02 Aspirina en dosis baja con liberacion controlada. Expired - Lifetime ES2076975T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/293,832 US4970081A (en) 1989-01-03 1989-01-03 Controlled-release, low-dose aspirin formulation and method of treating vascular occlusive disease therewith
US42662089A 1989-10-24 1989-10-24

Publications (1)

Publication Number Publication Date
ES2076975T3 true ES2076975T3 (es) 1995-11-16

Family

ID=26968181

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90100032T Expired - Lifetime ES2076975T3 (es) 1989-01-03 1990-01-02 Aspirina en dosis baja con liberacion controlada.

Country Status (20)

Country Link
EP (1) EP0377439B1 (es)
JP (1) JP2966871B2 (es)
KR (1) KR0151590B1 (es)
AR (1) AR244548A1 (es)
AT (1) ATE127690T1 (es)
AU (1) AU622254B2 (es)
CA (1) CA2006975C (es)
DE (1) DE69022251T2 (es)
DK (1) DK0377439T3 (es)
ES (1) ES2076975T3 (es)
FI (1) FI95776C (es)
GR (1) GR3017576T3 (es)
HK (1) HK35396A (es)
IE (1) IE69270B1 (es)
IL (1) IL92854A (es)
MX (1) MX174376B (es)
MY (1) MY104871A (es)
NO (1) NO177127C (es)
NZ (1) NZ231954A (es)
PT (1) PT92780B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5851579A (en) * 1996-10-28 1998-12-22 Eastman Chemical Company Aqueous enteric coating compositions
IL133405A0 (en) * 1997-06-11 2001-04-30 Procter & Gamble Film-coated tablet for improved upper gastrointestinal tract safety
AU2006203890A1 (en) * 2005-01-06 2006-07-13 Gilead Sciences, Inc. Sustained release pharmaceutical formulations comprising ranolazine
WO2008140459A1 (en) * 2007-05-16 2008-11-20 Fmc Corporation Solid form
KR101109633B1 (ko) * 2007-08-03 2012-01-31 제이더블유중외제약 주식회사 활성성분의 코팅막이 보호되는 구강내붕해제형을 제조하기위한 조성물
US11253484B2 (en) * 2018-01-30 2022-02-22 Nitto Denko Corporation Transdermal absorption preparation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0064485B1 (en) * 1981-04-27 1985-07-24 Aktiebolaget Hässle New pharmaceutical preparation
GB8519310D0 (en) * 1985-07-31 1985-09-04 Zyma Sa Granular active substances
GB8521494D0 (en) * 1985-08-29 1985-10-02 Zyma Sa Controlled release tablet
AU618589B2 (en) * 1988-04-05 1992-01-02 Kyowa Hakko Kogyo Co. Ltd. Oral compositions for ruminants
US4866046A (en) * 1988-05-31 1989-09-12 Top Laboratories, Inc. Low-dosage sublingual aspirin

Also Published As

Publication number Publication date
JP2966871B2 (ja) 1999-10-25
NO177127B (no) 1995-04-18
DE69022251D1 (de) 1995-10-19
CA2006975C (en) 2000-04-04
IE69270B1 (en) 1996-08-21
EP0377439B1 (en) 1995-09-13
MX18883A (es) 1993-09-01
KR0151590B1 (ko) 1998-10-15
JPH02262520A (ja) 1990-10-25
MX174376B (es) 1994-05-11
FI900017A0 (fi) 1990-01-03
PT92780A (pt) 1990-07-31
FI95776C (fi) 1996-03-25
MY104871A (en) 1994-06-30
HK35396A (en) 1996-03-08
NO900009L (no) 1990-07-04
IL92854A (en) 1994-11-28
GR3017576T3 (en) 1995-12-31
KR900011453A (ko) 1990-08-01
AR244548A1 (es) 1993-11-30
NO900009D0 (no) 1990-01-02
AU4719489A (en) 1990-07-12
NZ231954A (en) 1991-12-23
FI900017L (fi) 1990-07-04
EP0377439A2 (en) 1990-07-11
NO177127C (no) 1995-07-26
DK0377439T3 (da) 1995-10-30
DE69022251T2 (de) 1996-05-02
IL92854A0 (en) 1990-09-17
IE894120L (en) 1990-07-03
EP0377439A3 (en) 1991-02-06
PT92780B (pt) 1997-12-31
ATE127690T1 (de) 1995-09-15
CA2006975A1 (en) 1990-07-03
FI95776B (fi) 1995-12-15
AU622254B2 (en) 1992-04-02

Similar Documents

Publication Publication Date Title
ES2037082T3 (es) Una composicion para la liberacion controlada de un farmaco.
ES2139798T3 (es) Matriz de liberacion controlada para productos farmaceuticos.
ES2191034T3 (es) Formulaciones de liberacion controlada para la liberacion de metoprolol durante 24 horas.
ES2128369T3 (es) Procedimiento para la fabricacion de formas farmaceuticas solidas con liberacion prolongada en dos etapas.
BR9406363A (pt) Composiçao farmacêutica processo para a preparaçao da mesma uso da mesma e processo para o tratamento de doenças relacionadas com o ácido gástrico
ES2152966T3 (es) Formas de dosificado farmaceuticas de desleido rapido y procedimiento para su preparacion.
ES2057124T3 (es) Producto terapeutico para el tratamiento de estados peri- o post-menopausicos.
ES2157944T3 (es) Nucleos de pastillas de liberacion inmediata de medicamentos insolubles que poseen un recubrimiento de liberacion sostenida.
ES2149768T3 (es) Conjugados de agentes enlazantes de celulas derivados de cc-1065.
AR002754A1 (es) Composición farmacéutica que comprende bacterias lactobacillus viables micro-encapsuladas, y uso de la composición para preparar de un medicamento
UY26493A1 (es) " forma de dosificación de fármaco en capas impulsada por hidrogel"
ES2162517T3 (es) Composicion farmaceutica que comprende una combinacion de metformin y fibrato y su uso en la preparacion de medicamentos destinados a reducir la hiperglicemia.
IT7849462A0 (it) Corpo di capsula in particolare per una capsula per la somministrazione di sostanze medicamentose come pure procedimento e dispositivo per lasua produzione
ES2054716T3 (es) Bis-naftalimidas, su obtencion y empleo.
ES2027005T3 (es) Procedimiento para preparar una formulacion farmaceutica de liberacion controlada de acrivastina.
ES2082833T3 (es) Uso de monooleina en el tratamiento de la bolsa periodontal.
ES2111547T3 (es) Comprimido de liberacion prolongada.
ES2045194T3 (es) Un procedimiento para obtener preparaciones farmaceuticas comprimidasy moldeadas.
CO4940406A1 (es) Composiciones de paracetamol de accion rapida
ES2029776T1 (es) Procedimiento para la preparacion de composiciones farmaceuticas que contienen bromocriptina con una alta estabilidad.
ATE7105T1 (de) Zahnmedizinische wurzelfuellpaste.
ES2076975T3 (es) Aspirina en dosis baja con liberacion controlada.
DE69706748D1 (de) Oral anzuwendende Matrixtabletten mit verzögerter Wirkstoffabgabe enthaltend Tianeptin Natriumsalz
SE8703632D0 (sv) Sustained release fluoride composition
FI933975A0 (fi) Tabletter som kontrollerat avgiver naproxen

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 377439

Country of ref document: ES